FOXO4-DRI regulatory status

Common names: Foxo4-DRI

PeptSense tracks FOXO4-DRI across federal 503A Bulks List chain steps, PCAC advisory context, and state board positions. Status is never inferred from forums or marketing sites — only published citations with effective dates.

Federal 503A snapshot (illustrative)

Latest published federal event for 503A compounding pharmacies. Sign in for your licensed states and facility type.

Unclear
Summary
Honest expansion baseline (2026-08-12): no confident Bulks List / USP / approved-component chain step assigned for FOXO4-DRI in this pass. Unclear until substance-specific citation is curated. Not a legal determination.
Citation
FDA — 503A bulk drug substances page
Effective
Aug. 12, 2026

Not a legal determination. Replace placeholder citations during curation.

Run a full lookup

Get federal + state lanes, chain steps, printable answer cards, and compliance documents for the states you license in.

Related research topics

  • FOXO4-DRI legality
  • FOXO4-DRI compounding

← All peptides · Resources hub